BCAS4 Polyclonal Antibody
| Code | Size | Price |
|---|
| E-AB-16277-20uL | 20uL | £125.00 |
Quantity:
| E-AB-16277-60uL | 60uL | £172.00 |
Quantity:
| E-AB-16277-120uL | 120uL | £237.00 |
Quantity:
| E-AB-16277-200uL | 200uL | £344.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rabbit
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Human
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Immunohistochemistry (IHC)
- Western Blot (WB)
Shipping:
Ice packs
Storage:
-20°C
Further Information
Abbreviation:
BCAS4
Background:
The gene encoding BCAS4 (Breast carcinoma-amplified sequence 4), a 211 amino acid protein, is found in a region on chromosome 20 that is frequently amplified in human breast cancer.The amplification and translocation between the BCAS4 gene and the BCAS3 gene, with a 17q23 locus, results in a fusion transcript that is overexpressed in MCF-7 cells. Also, deletion of chromosomal region 20q13.13-q13.2 and resultant deletion of BCAS4, as well as three other genes, is the cause of Okihiro syndrome, a disease characterized by ocular and upper limb anomalies.
Buffer:
PBS with 0.05% sodium azide and 50% glycerol, PH7.4
Calculated MW:
23kDa
Concentration:
0.6 mg/mL
Conjugation:
Unconjugated
Dilution:
WB 1:500-1:2000, IHC 1:50-1:200
Immunogen:
Synthetic peptide of human BCAS4
Purification method:
Affinity purification
Target Synonym:
BCAS4;BCAS4/BCAS3 fusion;BCAS4;Breast carcinoma amplified sequence 4;Breast carcinoma amplified sequence 4/3 fusion protein;Breast carcinoma-amplified sequence 4;CNOL;FLJ20495;RP5-1071L10.2
UNIProt ID:
Q8TDM0